Supply Chain Intelligence

Kalaris Therapeutics, Inc. Supply Chain

KLRS supply chain intelligence for Kalaris Therapeutics, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

KLRS ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

4Suppliers
0Customers
1Debt Items
20Related Chains

Kalaris Therapeutics, Inc. Suppliers

TickerNameConfidenceEvidence
KBI-BIOPHARMA KBI-BIOPHARMA 90% Additionally, KBI Biopharma, based in North Carolina, is our Contract Development and Manufacturing Organization ("CDMO") for future clinical and commercial supply manufacturing of TH103 drug substance.
SHARP-STERILE-MANUFACTURING SHARP-STERILE-MANUFACTURING 90% Our principal contract manufacturers are STC Biologics, Inc. and Sharp Sterile Manufacturing (formerly, Berkshire Sterile Manufacturing Inc.).
STC-BIOLOGICS-INC STC-BIOLOGICS-INC 90% Our principal contract manufacturers are STC Biologics, Inc. and Sharp Sterile Manufacturing (formerly, Berkshire Sterile Manufacturing Inc.).
UCSD UCSD 90% Under the UCSD Agreement, the Company is required to make annual license maintenance payments of $ 10,000 during the first four anniversaries and $ 15,000 on the fifth and every subsequent anniversar…

Kalaris Therapeutics, Inc. Customers

No clients on recordNo downstream customers found in our database for Kalaris Therapeutics, Inc..

Kalaris Therapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
KLRS-DEBT-10529 Xbrl Convertible 90% xbrl convertible detail from xbrl 2025-12-31.

Kalaris Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Kalaris Therapeutics, Inc..

Kalaris Therapeutics, Inc. Ownership

HolderNameConfidenceEvidence
KLRS-OWNER-SAMSARA-BIOCAPITAL-LLC SAMSARA BIOCAPITAL, LLC 90% 13F overlay lists SAMSARA BIOCAPITAL, LLC as top holder; 58 tracked holders.

Kalaris Therapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
VNDA Vanda Pharmaceuticals Inc. 100.00 2
ALEC Alector, Inc. 100.00 2
SDGR Schrödinger, Inc. 100.00 2
CPMV Mosaic ImmunoEngineering, Inc. 100.00 2
NVO Novo Nordisk A/S 100.00 2
CTNM Contineum Therapeutics, Inc. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
SLGL Sol-Gel Technologies Ltd. 100.00 2
ALNY Alnylam Pharmaceuticals, Inc. 100.00 2
DAWN Day One Biopharmaceuticals Inc 100.00 2
FHTX Foghorn Therapeutics Inc. 100.00 2
AXSM Axsome Therapeutics, Inc. 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
AKTS Aktis Oncology, Inc. 100.00 2
EDSA Edesa Biotech, Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
BNBX BNB Plus Corp. 100.00 2
CHRS Coherus Oncology, Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
BYSI BeyondSpring Inc. 100.00 2
View KLRS supply chain intel →

Explore the full interactive supply chain map for Kalaris Therapeutics, Inc..

Open KLRS supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map